95 results
Pediatric SVT - Management Algorithm
Identify SVT:
 • HR not variable
 • Abrupt rate changes
 • Infants:
Pediatric SVT - Management ... Monitors, Pads AP Stable ... Don't cover mouth/nose ... Sync - 0.5-1 ... #tachycardia #Management
Hormones Acting on the Nephron - Diuretics and Their Site of Action
 1) Acetazolamide
 2) Osmotic
Site of Action 1) ... Loop Diuretics (e.g ... 4) Thiazides (e.g ... spironolactone) #Pathophysiology ... #Nephrology #Nephron
Nephron Pathophysiology - Diuretic Sites of Action
Diuretics
1) Acetazolamide/canagliflozin
2) Osmotic agents (mannitol, urearetics)
3) Loop agents (eg, furosemide)
4)
Nephron Pathophysiology ... Action Diuretics 1) ... ) Loop agents (eg ... Adenosine #Nephron #Pathophysiology ... Sites #Action #nephrology
Renal Tubular Acidosis (RTA) Diagnosis and Management
 • Distal (type 1) RTA
 • Proximal (type 2)
Diagnosis and Management ... • Distal (type 1) ... Acidosis #Diagnosis #Management ... #nephrology #table
Anaphylaxis: Signs and Symptoms
Anaphylaxis: when any egg of three conditions is met:
1. Acute onset of skin/mucosal
Anaphylaxis: when any egg ... conditions is met: 1. ... involvement with 2 1 ... known allergen Note ... #Anaphylaxis #pathophysiology
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... mg per day) > 1 ... year • AmBd (1 ... Meningoencephalitis #IDSA ... #Treatment #management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Perforation) Pathophysiology ... Epidemiology: • #1 ... • Note: Fidaxomicin ... Bezlotoxumab 10 mg/kg ... IV x 1 - Adjunct
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... 1) Antibiotics ... Echinocandins (e.g ... #Candidemia #IDSA
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... 1–5, 10, 17, 24 ... 1–5, 10, 17, 24 ... Prevention #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... 4–6 mL QID or 1– ... Prevention #Treatment #management